Respect this contrarian downgrade from a high-accuracy firm despite bullish consensus. Consider reducing long exposure or buying downside protection ahead of August earnings, as the elevated short interest and institutional trimming confirm near-term risk.
Price Chart
Executive Summary
Morgan Stanley double downgraded from Overweight to Equal-Weight with a $502 price target of $502, a 15% upside from the current $436.62. This is a contrarian call against a heavily bullish consensus (84% Buy). Morgan Stanley carries a top-tier 67% accuracy on 12 calls and avg return of 10.2%. Consensus mean target is $505.91, median $520 — the firm’s PT sits slightly below both. EPS estimates have been revised up across all periods in the last 7 and 30 days, with zero downward revisions. Short interest is elevated at 55.2%, aligning with the bearish signal. Insider sales from February total ~$2.1M from non-C-suite, a weak negative.73 institutional trimming by FMR (-44%) and Sound Shore (-30%) adds caution. Bottom line: the downgrade is a significant deviation from consensus and should be respected as a near-term negative, though the still-positive PT suggests limited downside.
Impact Score
Consensus & Targets
Consensus is overwhelmingly bullish: 11 Strong Buy, 25 Buy, 7 Hold, 0 Sell among 43 analysts. That is 84% Buy-rated. The downgrade from a top-tier firm stands sharply against this bullish majority, increasing its informational significance.
Current price $436.62. Consensus mean target $505.91 (implied upside 15.9%), median $520, high $575, low $355. Morgan Stanley's $502 PT of $502 is slightly below mean and significantly below the $520 median — indicating they are among the most cautious analysts on the street.
Recent Analyst Activity
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-05-18 | Morgan Stanley | downgrade | Equal-Weight | — |
| 2026-05-15 | UBS | maintain | Buy | $515.00 |
| 2026-05-15 | Citigroup | maintain | Buy | $550.00 |
| 2026-05-15 | B of A Securities | maintain | Buy | $540.00 |
| 2026-05-15 | Deutsche Bank | maintain | Buy | $550.00 |
| 2026-05-15 | Evercore ISI Group | maintain | Outperform | $515.00 |
| 2026-05-15 | TD Cowen | maintain | Buy | $525.00 |
| 2026-05-15 | B. Riley Securities | maintain | Buy | $550.00 |
| 2026-05-15 | Wolfe Research | maintain | Outperform | $550.00 |
| 2026-05-15 | JP Morgan | maintain | Overweight | $515.00 |
30-day analyst activity: 2 upgrades, 1 downgrade (this one). EPS revisions are uniformly positive: all periods (current Q0, +1q, 0y, +1y) have seen upward revisions in both the last 7 and 30 days, with zero downward revisions in the past 7 days. Estimates are being revised higher, in the opposite direction of this downgrade, creating a divergence.
Firm Track Record — Morgan Stanley
Morgan Stanley accuracy: 55% on 4993 calls | avg return: 4.3%
Industry benchmark: mean 51% ± 11%. Top tier: ≥61% (mean + 1σ). Based on 15 firms with ≥5 scored calls.
| Firm | Accuracy | Calls | Avg Return | vs Average |
|---|---|---|---|---|
| Jefferies | 100% | 3/3 | 18.3% | top tier |
| Evercore ISI Group | 80% | 4/5 | 11.8% | top tier |
| Keybanc | 75% | 3/4 | 21.4% | top tier |
| UBS | 75% | 3/4 | 30.5% | top tier |
| Deutsche Bank | 75% | 3/4 | 6.3% | top tier |
| Barclays | 67% | 4/6 | 8.5% | top tier |
| Morgan Stanley | 67% | 8/12 | 10.2% | top tier |
| Goldman Sachs | 67% | 2/3 | 8% | top tier |
| Citigroup | 63% | 5/8 | 16.7% | top tier |
| B of A Securities | 60% | 3/5 | 23.9% | above average |
Morgan Stanley has a 67% accuracy on 12 calls on this stock with an average return of 10.2%, firmly in the top tier. By comparison, Jefferies leads at 100% on 3 calls, Evercore 80% on 5, Keybanc 75% on 4. The weakest firm covering is TD Cowen at 50% on 2 calls. Morgan Stanley’s record supports taking this downgrade seriously.
Earnings Estimates
Next earnings: Aug 12, 2026
| Period | EPS Est. | EPS Range | Revenue | Revisions (7d) |
|---|---|---|---|---|
| 0q | $3.38 | $3.17 — $3.56 | $9.0B | ↑2 ↓0 |
| +1y | $15.91 | $12.48 — $18.73 | $41.4B | ↑3 ↓0 |
| +1q | $3.59 | $3.28 — $3.86 | $9.4B | ↑2 ↓0 |
| 0y | $12.27 | $11.51 — $13.58 | $33.2B | ↑3 ↓0 |
Cross-Platform Signals
Insider sales: three sells in Feb 2026 totaling ~$2.1M from non-C-suite (Judy Bruner, Adam Sanders) — weak signal per literature. Congressional: one small sell by Rep. Boozman (R). Institutional changes are mixed: Two Sigma added 70% but FMR trimmed 44% and Sound Shore trimmed 30%. Short interest is elevated at 55.2%, a bearish signal that converges with the downgrade. Overall, cross-platform signals are mixed but short interest lends support to the negative view.
Investment Themes
Documents Analyzed
Report based on filing metadata.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jun 17, 2026 15w ago | Insider Cluster | $617.11 $424.21 | ▼ −31.26% | ▼ −33.15% | $540.17 (−12.47%) |
Jun 17, 2026 15w ago | Insider Cluster | $617.11 $424.21 | ▼ −31.26% | ▼ −33.15% | $540.17 (−12.47%) |
Jun 17, 2026 15w ago | Insider Cluster | $617.11 $424.21 | ▼ −31.26% | ▼ −33.15% | $540.17 (−12.47%) |
Jun 16, 2026 15w ago | Press Release | $568.23 $454.01 | ▼ −20.10% | ▼ −21.10% | $540.17 (−4.94%) |
Jun 9, 2026 16w ago | Press Release | $499.21 $438.46 | ▼ −12.17% | ▼ −15.98% | $540.17 (+8.20%) |
Jun 5, 2026 16w ago | Insider Cluster | $492.17 $441.69 | ▼ −10.26% | ▼ −13.31% | $540.17 (+9.75%) |
May 28, 2026 18w ago | Insider Cluster | $450.23 $484.19 | ▲ +7.54% | ▲ +6.62% | $540.17 (+19.98%) |
May 18, 2026 19w ago | ANALYST-DOWNGRADE | $413.27 $547.66 | ▼ −32.52% | ▼ −27.94% | $540.17 (−30.71%) |
May 14, 2026 20w ago | 8-K | $435.77 $525.02 | ▲ +20.48% | ▲ +16.24% | $540.17 (+23.96%) |
May 14, 2026 20w ago | Press Release | $435.77 $525.02 | ▼ −20.48% | ▼ −16.24% | $540.17 (−23.96%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access